Functional implications of antiestrogen induction of quinone reductase: Inhibition of estrogen-induced deoxyribonucleic acid damage

Molecular Endocrinology

Volumn 17, Issue 7, 2003, Pages 1344-1355

  Bianco, Nicole R ^a   Perry, George ^a   Smith, Mark A ^a   Templeton, Dennis J ^b   Montano, Monica M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANINE; 8 HYDROXYGUANINE; ANTIESTROGEN; CATECHOL ESTROGEN; DNA; ESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; HYDROXYTAMOXIFEN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RALOXIFENE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CELL PROTECTION; CELL STRAIN; CELL STRAIN MCF 10A; CELL STRAIN MCF 7; CELL STRAIN MDA MBA 231; CONTROLLED STUDY; DETOXIFICATION; DNA ADDUCT; DNA DAMAGE; ENZYME INDUCTION; ESTROGEN METABOLISM; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; RECEPTOR BLOCKING;

BREAST NEOPLASMS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; FEMALE; GUANINE; HUMANS; NAD(P)H DEHYDROGENASE (QUINONE); OXIDATIVE STRESS; RALOXIFENE; RECEPTORS, ESTROGEN; TAMOXIFEN; TUMOR CELLS, CULTURED; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0037634342     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0382     Document Type: Article

References (57)

1. Newbold RR, Liehr JG 2000 Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 60:235-237
2. Liehr JG 1997 Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens. Eur J Cancer Prev 6:3-10
3. Liehr JG 2000 Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21:40-54
4. Russo J, Hu YF, Tahin Q, Mihaila D, Slater C, Lareef MH, Russo IH 2001 Carcinogenicity of estrogens in human breast epithelial cells. APMIS 109:39-52
5. Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, Naftolin F, Mor G, Berstein L 2000 Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 27:95-112
6. Zhu BT, Conney AH 1998 Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1-27
7. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR 1998 Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19:291-298
8. Thibodeau PA, Paquette B 1999 DNA damage induced by catecholestrogens in the presence of copper (II): generation of reactive oxygen species and enhancement by NADH. Free Rad Biol Med 27:1367-1377
9. Raftogianis R, Creveling C, Weinshilboum R, Weisz J 2000 Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 27:113-124
10. Roy D, Liehr JG 1988 Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. Increased superoxide formation by redox cycling of estrogen. J Biol Chem 263:3646-3651
11. Shen L, Pisha E, Huang Z, Pezzuto JM, Krol E, Alam Z, van Breemen RB, Bolton JL 1997 Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis 18:1093-1101
12. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388
13. Veronesi U, Maisonneuve P, Rotmensz N, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Lovison F, Gucciardo G, Muraca MG, Pizzichetta MA, Conforti S, Decensi A, Robertson C, Boyle P 2003 Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. J Natl Cancer Inst 95:160-165
14. Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, Farrerons J, Karasik A, Mellstrom D, Ng KW, Stepan JJ, Powles TJ, Morrow M, Costa A, Silfen SL, Walls EL, Schmitt H, Muchmore DB, Jordan VC, Ste-Marie LG 2001 Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple Outcomes of Raloxifene Evaluation. Breast Cancer Res Treat 65:125-134
15. Montano MM, Katzenellenbogen BS 1997 The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 94:2581-2586
16. Montano MM, Jaiswal AK, Katzenellenbogen BS 1998 Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-α and estrogen receptor-β. J Biol Chem 273:25443-25449
17. Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT 1999 Expression of wild-type estrogen receptor β and variant isoforms in human breast cancer. Cancer Res 59:5425-5428
18. Hu YF, Lau KM, Ho SM, Russo J 1998 Increased expression of estrogen receptor β in chemically transformed human breast epithelial cells. Int J Oncol 12:1225-1228
19. Girdler F, Browell DA, Cunliffe WJ, Shenton BK, Hemming JD, Scorer P, Young JR, Brotherick I 2001 Use of the monoclonal antibody DAKO-ERβ (8D5-1) to measure oestrogen receptor β in breast cancer cells. Cytometry 45:65-72
20. Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW, Yager JD 2001 The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res 61:7488-7494
21. Hiraku Y, Yamashita N, Nishiguchi M, Kawanishi S 2001 Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation. Int J Cancer 92:333-337
22. Helbock HJ, Beckman KB, Ames BN 1999 8-Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. Methods Enzymol 300:156-166
23. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA 2001 Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767
24. Nunomura A, Chiba S, Kosaka K, Takeda A, Castellani RJ, Smith MA, Perry G 2002 Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. Neuroreport 13:2035-2039
25. Pilat MJ, Cristman JK, Brooks SC 1996 Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6. Breast Cancer Res Treat 37:253-266
26. Garcia M, Derocq D, Freiss G, Rochefort H 1992 Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 89:11538-11542
27. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA 1999 RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19:1959-1964
28. Paulus W, Baur I, Boyce FM, Breakfield XO, Reeves SA 1996 Self-contained, tetracline regulated retroviral vector system for gene delivery to mammalian cells. J Virol 70:62-67
29. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M, Gustafsson J-A 2002 Estrogen receptor β in breast cancer. Endocr Relat Cancer 9:1-13
30. Tong D, Schuster E, Seifert M, Czerwenka K, Leodolte S, Zeillinger R 2002 Expression of estrogen receptor β isoforms in human breast cancer tissues and cell lines. Breast Cancer Res Treat 71:249-255
31. Croteau DL, Bohr VA 1997 Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 272:25409-25412
32. Reardon JT, Bessho T, Kung HC, Bolton PH, Sancar A 1997 In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Natl Acad Sci USA 94:9463-9468
33. Jaiswal M, Lipinski LJ, Bohr VA, Mazur SJ 1998 Efficient in vitro repair of 7-hydro-8-oxodeoxyguanosine by human cell extracts: involvement of multiple pathways. Nucleic Acids Res 26:2184-2191
34. Driggers WJ, Grishko VI, LeDoux SP, Wilson GL 1996 Defective repair of oxidative damage in the mitochondrial DNA of a xeroderma pigmentosum group A cell line. Cancer Res 56:1262-1266
35. Lipinski LJ, Hoehr N, Mazur SJ, Dianov GL, Senturker S, Dizdaroglu M, Bohr VA 1999 Repair of oxidative DNA base lesions induced by fluorescent light is defective in xeroderma pigmentosum group A cells. Nucleic Acids Res 27:3153-3158
36. Klein JC, Bleeker MJ, Saris CP, Roelen HC, Brugghe HF, van den Elst H, van der Marel GA, van Boom JH, Westra JG, Kriek E 1992 Repair and replication of plasmids with site-specific 8-oxodG and 8-AAFdG residues in normal and repair-deficient human cells. Nucleic Acids Res 20:4437-4443
37. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D 2000 Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75-93
38. Shibutani S, Grollman AP 1994 Miscoding during DNA synthesis on damaged DNA templates catalysed by mammalian cell extracts. Cancer Lett 83:315-322
39. Li D, Zhang W, Zhu J, Chang P, Sahin A, Singletary E, Bondy M, Hazra T, Mitra S, Lau SS, Shen J, DiGiovanni J 2001 Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol Carcinog 31:214-223
40. Musarrat J, Arezina-Wilson J, Wani AA 1996 Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 32A:1209-1214
41. 1998 Williams textbook of endocrinology. In: Wilson JD, Foster DW, Kronenberg H, Larsen PR, eds. 9th ed. Philadelphia: WB Saunders Company
42. Liehr JG, Gladek A, Macatee T, Randerath E, Randerath K 1991 DNA adduct formation in liver and kidney of male Syrian hamsters treated with estrogen and/or α-naphthoflavone. Carcinogenesis 12:385-389
43. Thibodeau PA, Kachadourian R, Lemay R, Bisson M, Day BJ, Paquette B 2002 In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem Mol Biol 81:227-236
44. Okubo T, Nagai F, Ushiyama K, Yokoyama Y, Ozawa S, Kano K, Tomita S, Kubo H, Kano I 1998 DNA cleavage and 8-hydroxydeoxyguanosine formation caused by tamoxifen derivatives in vitro. Cancer Lett 122:9-15
45. Wei H, Cai Q, Tian L, Lebwohl M 1998 Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo. Carcinogenesis 19:1013-1018
46. Jain S, Saxena D, Kumar PG, Koide SS, Laloraya M 1999 Effect of estradiol and selected antiestrogens on pro- and antioxidant pathways in mammalian uterus. Contraception 60:111-118
47. Ross D, Siegel D, Beall H, Prakash AS, Mulcahy RT, Gibson NW 1993 DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C. Cancer Metastasis Rev 12:83-101
48. Roy D, Liehr JG 1990 Inhibition of estrogen-induced kidney carcinogenesis in Syrian hamsters by modulators of estrogen metabolism. Carcinogenesis 11:567-570
49. Gustafsson J, Warner M 2000 Estrogen receptor β in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 74:245-248
50. Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, Li Y, Younes M 2001 Estrogen receptor B expression in invasive breast cancer. Hum Pathol 32:113-118
51. Hector S, Bolanowska-Higdon W, Zdanowicz J, Hitt S, Pendyala L 2001 In vitro studies on the mechanisms of oxaliplatin resistance. Cancer Chemother Pharmacol 48:398-406
52. Bange J, Zwick E, Ullrich A 2001 Molecular targets for breast cancer therapy and prevention. Nat Med 7:548-552
53. Kensler TW, Curphey TJ, Maxiutenko Y, Roebuck BD 2000 Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol Drug Interact 17:3-22
54. Shaw PM, Reiss A, Adesnik M, Nebert DW, Schembri J, Jaiswal AK 1991 The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4. Eur J Biochem 195:171-176
55. Raina AK, Templeton DJ, Deak JC, Perry G, Smith MA 1999 Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Rep 4:23-27
56. Bianco NR, Montano MM 2002 Regulation of prothymosin α by estrogen receptor α: molecular mechanisms and relevance in estrogen-mediated breast cell growth. Oncogene 21:5233-5244
57. Chai Y, Shao J, Miller VM, Williams A, Paulson HL 2002 Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci USA 99:9310-9315